Stock of the Day

Quest Diagnostics (DGX)

$172.44

+$0.30 (+0.2%)

Market Cap: $19.21B

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Recent News

• Quest Diagnostics Incorporated (NYSE:DGX) EVP Sells $90,794.85 in Stock (insidertrades.com)
• Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight (gurufocus.com)
• Top Executives Make Strategic Moves with Quest Diagnostics Stock (tipranks.com)
• Quest Diagnostics Inc (DGX) Employee Shares Positive Work Experience (gurufocus.com)
• Quest Diagnostics Q4 Earnings Transcript (marketbeat.com)
• 3 Reasons to Avoid DGX and 1 Stock to Buy Instead (msn.com)
• Is There An Opportunity With Quest Diagnostics Incorporated's (NYSE:DGX) 50% Undervaluation? (finance.yahoo.com)